價格 | ¥34600 |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:EGFRVIII, Human, 重組蛋白 (His & Avi), Biotinylated | 英文名稱:EGFRVIII Protein, Human, Recombinant (His & Avi), Biotinylated |
品牌: TargetMol | 產(chǎn)地: 美國 |
保存條件: Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. | 產(chǎn)品類別: 抑制劑 |
貨號: TMPK-00692 |
名稱 | EGFRVIII Protein, Human, Recombinant (His & Avi), Biotinylated |
描述 | The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. EGFRVIII Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 41.6 kDa and the accession number is NP_001333870.1. |
存儲條件 | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. |
關鍵字 | HER-1 | ERBB 1 | NISBD-2 | PIG-61 | HER 1 | ERBB-1 | PIG 61 | NISBD 2 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學試劑,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥1950 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2024-12-30 | |
詢價 |
VIP2年
|
北京百普賽斯生物科技股份有限公司
|
2024-12-16 | |
¥2460 |
VIP6年
|
上海澤葉生物科技有限公司
|
2024-12-30 |